Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Only 3% of shares needed to add nominee..... New SEC rule change !!
Reply New Message
Prev Message Back To Forum Threaded View Next Message

As Chevron has been used previously for comparison of change of control provisions, I humbly suggest you apply the same "amusement" to the respective holdings of their BoD:

0.02%

http://finance.yahoo.com/q/ks?s=cvx

http://www.secform4.com/insider-trading/93410.htm

Approximately 99% lower than that of PTSC's BoD.

.

.

.

Be well

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply